Navigation Links
RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board
Date:1/5/2009

IRVING, Texas, Jan. 5 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL) announced today that it has elected current president, John W. Price, to CEO effective January 1, 2009. Company founder, Clinton Howard, who is currently CEO, will remain as chairman of the board of directors.

The promotion comes at a time when RBC Life Sciences, a global provider of proprietary nutritional supplements, wound care and pain management products, is growing domestically and internationally. The company announced recently that third quarter net sales and earnings both increased 26 percent over the same period last year.

"John possesses the perfect skill set to take RBC Life Sciences to the next level," said Mr. Howard, who founded the company in 1991. "He has the vision, leadership and focus needed to pilot a multinational company to the forefront of its industry."

A retired U.S. naval commander, Price was named president of RBC Life Sciences in December 2007. He will retain the position of president after being promoted to CEO January 1. Prior to joining the company, he served as a senior executive for two major companies that market nutritional supplements domestically and internationally. Price also led a successful management consulting company and spent 17 years as a senior officer of pharmaceutical giant Eli Lilly.

"It's an exciting time for RBC Life Sciences," said Price, a triathlon athlete who practices the healthy nutrition and exercise promoted by the company. "We're redoubling our efforts to grow our North American market while undertaking aggressive international expansion. We have a healthy balance sheet driven by sales of nutritional supplements and medical device products that are backed by science and are receiving increasing accolades within their industries."

The company's medical devices brand
'/>"/>

SOURCE RBC Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Life Sciences Discovery awards health research program grants
2. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
3. Laureate Education Names Dr. Francisco Gutierrez Senior Vice President for Medicine and Health Sciences
4. DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations
5. ZINO Societys Call for Life Sciences Entrepreneurs Seeking Funding
6. Human Genome Sciences to Sponsor Conference Call
7. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
8. Gene Network Sciences Announces Creation of Spin-off Entity Focused on Quantitative Finance and E-Commerce
9. BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
10. Growing Demand for High-Quality and Cost-Effective Imaging Equipment in Life Sciences
11. Burroughs Wellcome Fund award creates new Ph.D. path linking laboratory and population sciences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ina, Nov. 9 /PRNewswire-Asia/ -- Simcere Pharmaceu...ny"), a leading pharmaceutical company,specializin... of branded,generic and proprietary pharmaceutical...e the manufacturing license in China of Rosuvastat...Tianda"). The acquisition of the,manufacturing lic...
(Date:11/9/2009)... Lumension,s advanced device control capabilit...insider risk and quickly enhance their data securi...Scottsdale, AZ (PRWEB) Nov. 9, 2009 -- Lumension, ...y, today announced the general availability of Lu...enter (DCSC) to enable users to protect corporate...
(Date:11/9/2009)... Omnetics Connector Corporation announces that... certified. , Minneapolis...r Corporation, the leading manufacturer of miniatu...n, production and QA systems have been certified t..., International Quality System Standard., , ,The c...
(Date:11/9/2009)... Gifted young athletes are under increasing pressu...w Loyola University Health System study of 519 jun...ion increases the risk of injury. Researchers who ...ociation junior competition found that players who...thdraw from tournaments for medical reasons, typic...
(Date:11/8/2009)...lation would strengthen Medicare, improve coverage...wire-USNewswire/ -- SUMMARY: Yesterday the Unite...health care reform legislation that would strength...insurance companies that prices millions of Americ... Affordable Health Care for America Act (H.R. 3962...
Breaking Medicine News(10 mins):Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 2Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 3Health News:Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance 4Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4
... it,s worthwhile, expert says , , MONDAY, ...ors don,t seem to provide any particular benefit ...ds. , A defibrillator can provide a lifesaving ele...,s ability to pump blood nor does it help any life...
...mmon elective medical procedures , , EAGAN, Minn.... health care cost and quality information through ...oday by Blue Cross and Blue Shield of Minnesota. C...y information for dozens of common elective proced...
...- Hard to Treat Diseases (HTDS) www.htdsmedical.c...gators (lead by Professor Mirjana Stojiljkovic) fr...gical Research "Sinisa Stankovic", University of B...isease. The effectiveness of this therapy is shown...
...Eleanor Rogen of the University of Nebraska Medica... located in Omaha, Nebraska, have identified the t...ancer cells begin. Preventium http://www.preventi...esearch collaborator Eleanor Rogen, Ph.D. say: "We...
...o Medigap as Additional Coverage Option For Florid...SSEE, Fla., March 16 The National Kidney Foundati...d Altman and Representative Ritch Workman today fo...er age 65 who are facing challenges securing criti...
...ional, Inc.,(Nasdaq: DATA ), a technology and se...ns for the clinical trials industry, today announc...d full year of 2008. , Revenue for the fourth ...s ended December 31, 2008 compared to 48%,for the ...
Other Medicine News:Health News:Defibrillator May Not Help Many With Heart Failure 2Health News:Defibrillator May Not Help Many With Heart Failure 3Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 2Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 3Health News:Hard to Treat Diseases (HTDS) Releases experimental results in the treatment of (MS) Multiple Sclerosis 2Health News:The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida' 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 3Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 4Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 5Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 6Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 7Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 8Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 9Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 10
(Date:11/6/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...t in principle with the U.S. Department of Justice... Guidant subsidiary in 2005. The alleged conduct ...fic,s 2006 acquisition of Guidant. ,, Boston Sc... by the U.S. Attorney,s Office in Minneapolis into...
(Date:11/6/2009)...- Philips Respironics applauds the efforts of the ...o raise awareness about an important public health...elease of the first-ever government study to monit...a milestone in quantifying the size and scope of t...ry leader and sleep therapy manufacturer, Philips ...
(Date:11/6/2009).../ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a b... small-molecule therapeutics for the treatment of ...), today reported recent accomplishments and finan... ended September 30, 2009. ,, (Logo: http://...,, "Since our last quarterly update, we have co...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 1Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 2OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results 13322 1Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 1Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 2Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 3Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 4
...SOUTH SAN FRANCISCO, Calif. and ALLSCHWIL, Switzer...today that data,published in The Lancet(1) show th...tension (PAH) patients (WHO functional class II - ...al deterioration by significantly,delaying time to...ents,worsening to WHO FC III/IV. A significant red...
...SYDNEY, Australia, June 19 /Xinhua-PRNewswire-Firs... announced that the company and the U.S. Food,and ...n the phase 3,registration trial of Bronchitol for...t process., The SPA process allows for FDA evalua... the primary basis of an efficacy claim in support...
Other Medicine Technology:Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 2Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 3Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 4Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 5Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 6Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3
Moody Curved Fixation Forceps
Lindstrom Curved Pierce Forcep
Green Fixation Forceps
Kuhnt Fixation Forceps
Medicine Products: